Fiscal Year 2025 KEY HIGHLIGHTS$272.1M net revenue$194.7M adj. gross profit$16.1M Adj. Ebitda Results Events Latest Event Waldencast plc First Quarter Fiscal 2025 Earnings Call May 14, 2025 8:30 AM EDT Latest Event Waldencast plc Fourth Quarter Fiscal 2024 Earnings Call March 19, 2025 8:30 AM EDT All Events Press Releases Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act September 14, 2026 Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint July 30, 2026 All Press Releases Stock Chart Stock Information Minimum 15 minutes delayed. Source: LSEG
Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act September 14, 2026